Denice Torres
CIK 1820278 · last filed 2026-06-29
Denice Torres is a corporate insider who has filed 31 SEC Form 4 insider transactions across 7 companies since 2020. The most recent filing, for CLDX, was dated Jun 29, 2026. Current disclosed insider exposure totals $4.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.26M
7
31
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLDX | Director | — | $37.69 | — | $0 | 2 | 2026-06-29 |
| GKOS | Director | 24,212 | $164.85 | $3.99M | $0 | 12 | 2026-06-23 |
| SPTX | Director | 13,406 | $19.82 | $265.6K | $0 | 1 | 2026-05-04 |
| 2seventy bio, Inc. (TSVT) Delisted | Director | 31,560 | $5.00 | $157.8K | $0 | 4 | 2024-06-12 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | $0 | 5 | 2024-03-18 |
| Surface Oncology, Inc. (SURF) Delisted | Director | — | $1.07 | — | $0 | 3 | 2022-06-10 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 136 | $4.97 | $676 | $0 | 3 | 2021-11-17 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-29 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2026-06-23 | GKOS | Grant (A) | — | $0 | EDGAR |
| 2026-06-01 | GKOS | Grant (A) | +1,878 | $0 | EDGAR |
| 2026-05-04 | SPTX | Mixed | +13,406 | $0 | EDGAR |
| 2026-01-07 | GKOS | Grant (A) | +623 | $0 | EDGAR |
| 2025-06-09 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | GKOS | Grant (A) | +2,569 | $0 | EDGAR |
| 2025-05-15 | — | Mixed | −31,560 | $0 | |
| 2024-06-12 | 2seventy bio, Inc. (TSVT) Delisted | Grant (A) | +12,050 | $0 | EDGAR |
| 2024-06-03 | GKOS | Grant (A) | +1,716 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.